Attorneys general want Congress to prohibit PBMs from owning affiliated pharmacies

Taking stock of the drug industry, from the lab to the medicine chest

April 15, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

GEORGE FREY/AFP via Getty Images STAT+ | Attorneys general want Congress to prohibit PBMs from owning affiliated pharmacies They are concerned about conflicts of interest that allow PBMs to dominate health plan designs and distort the distribution and pricing of medicines. By Ed Silverman STAT+ | Universities begin search for indirect-cost fix that might assuage Trump administration With a proposed cap on NIH indirect research costs tied up in court, experts try to craft a 'predictable, sustainable' funding environment By Anil Oza Opinion: The NIH called my health equity research 'antithetical to scientific inquiry' NIH letters canceling funding for health equity research contain six demonstrably false claims. By Logan Beyer

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser